Document ID: chunk:federal_register_of_legislation:C2004A04008:body:0:p3
Version: federal_register_of_legislation:C2004A04008
Segment Type: other
Provision Reference: 
Character Range: 10850–13875

Commission';

'employment', in relation to a staff member, means employment by, or service with, CSL;

'group company' means:

      (a) CSL; or

      (b) a wholly-owned subsidiary of CSL;

    'member', in relation to CSL at any time before the transition, includes a Commissioner and the Managing Director;

    'memorandum' means memorandum of association;

    'operate', in relation to a name, has the meaning given by section 3a;

    'protected body' means a group company that is a trading corporation, or a financial corporation, within the meaning of paragraph 51 (20) of the Constitution;

    'protected business name' means any of the following names:

      (a) 'CSL';

      (b) 'Commonwealth Serum Laboratories';

      (c) such other names as are prescribed for the purposes of this definition;

    'protected company name' means any of the following names:

      (a) 'Commonwealth Serum Laboratories Limited';

      (b) such other names as are prescribed for the purposes of this definition;

    'protected name' means a protected business name or a protected company name;

    'protection time', in relation to a protected name, means the time immediately before:

        (a) in the case of a name prescribed for the purposes of the definition of 'protected business name' or 'protected company name'—the name first becoming prescribed; or

        (b) in any other case—the commencement of section 14 of the Commonwealth Serum Laboratories (Conversion into Public Company) Act 1990;

    'registered', in relation to a name, includes reserved;

    'share', in relation to CSL, means a share in the share capital of CSL;

    'staff member' means a person who, immediately before the transition is:

        (a) the Managing Director of CSL; or

        (b) an officer or employee of CSL;

   'subsidiary' has the meaning given by section 3b;

    'transferring asset' means an asset to which a determination under paragraph 31a (1) (a) applies;

    'transferring liability' means a liability to which a determination under paragraph 31a (1) (b) applies;

    'transition' means the commencement of Part IIb, being the Part inserted by section 13 of the Commonwealth Serum Laboratories (Conversion into Public Company) Act 1990;

'wholly-owned subsidiary', in relation to CSL, means a body corporate:

        (a) that is a subsidiary of CSL; and

        (b) none of whose members is a person other than:

           (i) CSL; or

           (ii) a body corporate that is, under any other application or applications of this definition, a wholly-owned subsidiary of CSL; or

           (iii) a nominee of CSL or of a body of a kind referred to in subparagraph (ii); and

        (c) no share in which is beneficially owned by a person other than:

           (i) CSL; or

           (ii) a body of a kind referred to in subparagraph (b) (ii).

Operating under a name

"3a. A reference in this Act to a protected body operating in a State or Territory under a particular name includes a reference